Stock Events

Stock Events

Alnylam Pharmaceuticals (ALNY.MX) Q3 2018 Earnings

2AugConfirmed

Q4 2017

Q1 2018

Q2 2018

Q3 2018

-34.12

-30.85

-27.58

-24.31

Details

Expected EPS

-32.072323999999995

Actual EPS

-34.123461

Surprise EPS

-2.05

Surprise Percent

+6.4%

Description

Alnylam Pharmaceuticals (ALNY.MX) has reported earnings of -34.123461 per share for Q3 2018.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.